Tenderwize
Zurück zur Suche

Open House Discount Agreements for Active Substance Molsidomin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 218 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Molsidomin, ATC C01DX12

75/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

75 / 100

Komplexität

25 / 100

Risikofaktoren

The buyer reserves the right to replace Open House agreements with exclusive contracts from future tenders at any time...

No estimated value is provided. Revenue depends entirely on actual prescriptions and market share. No minimum quantity...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Strong opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for pharmaceutical products with active substance Molsidomin (ATC C01DX12)
  • Supply of authorized and marketable drugs in Germany
Vollständige Zusammenfassung anzeigen

This is an Open House procedure for non-exclusive discount agreements (Rabattverträge) for pharmaceutical products containing the active substance Molsidomin (ATC C01DX12). The contracting authority is AOK Rheinland-Pfalz/Saarland. All interested pharmaceutical companies can join without selection. Contracts run for a maximum of 24 months (from 01.06.2025 to 31.05.2027) and can be terminated with 6 weeks' notice. The Open House may be replaced at any time by exclusive contracts from tendered procedures. Initial submission deadline for the first contract start (01.06.2025) is 30.04.2025; later entries are possible monthly. No estimated contract value is provided. The notice explicitly states that this is not a public procurement under EU law but published voluntarily for transparency.

Risiken

The buyer reserves the right to replace Open House agreements with exclusive contracts from future tenders at any time...

No estimated value is provided. Revenue depends entirely on actual prescriptions and market share. No minimum quantity...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Proof of marketability via Lauer-Taxe listing or AMIce database extracts

Eligibility

  • Only authorized and marketable drugs in Germany are eligible

Administrative

  • Signed contract documents must be submitted in original (electronic submission not allowed)

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No award criteria – open house with no selection; all eligible participants are accepted.

Auftraggeber

Lose (1)

LOT-0001

Open House Discount Agreements for Active Substance Molsidomin

Non-exclusive discount agreements for Molsidomin (ATC C01DX12) products. All pharmaceutical companies meeting eligibility can join. Contracts run up to 24 months, starting from 01.06.2025. No selection or negotiation; uniform terms for all participants. The buyer may replace these agreements with exclusive contracts from future tenders, leading to automatic termination.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

No award criteria – open house with no selection; all eligible participants are accepted.

Frist

Deadline Mar 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
236173-2025

Dokumente (1)

Ähnliche Ausschreibungen